NINDS Landis Award for Outstanding Mentorship (2026): Up to $100,000 per Mentor for Mentorship Excellence

Captured cycle: This page is retained for historical guidance. Confirm whether the program has reopened before planning an application.

NINDS Landis Award for Outstanding Mentorship (2026): Up to $100,000 per Mentor for Mentorship Excellence

The NINDS Landis Award for Outstanding Mentorship is one of the few NIH opportunities that is simultaneously a recognition mechanism and a performance-based cash-prize pipeline. It is not a research grant in the normal proposal model; it is a mentor-recognition competition converted from an administrative supplement model into a structured prize competition. Its stated purpose is to reward mentorship behavior that produces measurable impact in neuroscience training and career outcomes.

As of the page update in spring 2026, the opportunity is open with milestones that stretch from trainee nomination through winner selection. The process starts with trainee-driven nominations (no self-nomination), moves to invited eligibility-based full submission, then two-stage review (pre-screening/initial review, followed by judging and final selection). The page is explicit that up to five mentors can receive awards, with a total prize pool of $500,000 and each winner potentially receiving up to $100,000.

This is a genuine 2026 cycle opportunity and it is still relevant for 2026–2027 planning because nomination and review activity can overlap with hiring, lab strategy and mentorship documentation cycles that affect institutions over a multi-year period.

Key details table

What this opportunity is and is not

The program’s framing is important: this is not a travel fellowship, not trainee stipend support, and not a seed grant for a specific experiment. It is explicitly a mentoring award that may include a cash prize to the mentor’s employing institution.

What is different from classic NIH funding:

1. Nomination origin. Trainees initiate participation by nominating mentors directly. Mentors are not the first active actor. If you are a mentor, you do not apply in the way a PI submits an SBIR or R01; your path is nomination-based.
2. Two-stage structure. Trainee nomination alone does not guarantee a final submission. Nominated mentors must clear eligibility rules first, then move to a full submission phase.
3. Prize payment model. The award is paid to eligible institutions, not directly to mentors. That creates institutional buy-in requirements and internal review dynamics you must anticipate early.
4. Documentation-heavy evaluation. The competition explicitly asks for mentorship statements, publication evidence, trainee outcomes, CVs, grant references, recommendation letters, and institution approvals.

This design makes the Landis Award attractive for mentors with a track record of sustained mentee development, but it is less suitable for people expecting a classic one-page project grant where funding supports a new protocol.

Who this fits

Your odds improve when your profile matches one of the following realistic use cases.

Fits strongly when you are a mentor

You are most competitive if your profile is institutionally visible for mentoring outcomes and you can provide evidence across multiple dimensions:

• Long mentorship trajectory: you are at least 20 years from your first tenure-track/equivalent start date.
• Active NINDS funding status: you are a PI or mPI on one of the listed active FY26 NINDS mechanisms (R01, R35, U01, U54, P01, DP1, DP2 or equivalent 4–5 year award as of 10/1/2025).
• Mentoring outputs: you can identify concrete trainee outcomes, publications, placements, and career progression examples.
• Institutional support: leadership can provide formal approval if you are invited.

Fits strongly when you are a trainee and want to nominate

Trainee nominees are the entry point and the competition depends on them. A trainee nomination is practical when:

• You have first-hand experience with the mentor’s scientific and professional guidance,
• You can describe specific ways they improved rigor, mentoring quality, or career progression,
• You can provide nomination and recommendation materials that are credible and specific, and
• You represent the type of mentorship experience the award intends to reward.

The page is explicit that nominations should come directly from trainees and should not be solicited by mentors or institutions. That restriction matters.

Who to deprioritize

A mentor who cannot show institutional and documentation readiness, or who is already a prior winner, should defer this cycle. A mentor without current NINDS R01/R35/U01/U54/P01/DP1/DP2 equivalent standing is explicitly outside core eligibility. International institutions that are ineligible to receive institutional cash award may not be a fit.

Eligibility in practical terms

The page provides two separate rule blocks: mentor eligibility and institution eligibility. Treat these as independent filters.

Mentor eligibility checkpoints

1. Nominations: The mentor must receive at least two trainee-submitted nominations to be invited.
2. Tenure-track timing: Start date of first tenure-track or equivalent position must be in 2005 or earlier (20+ years threshold).
3. Active NINDS grant: Active status on a qualifying NINDS award in FY26 is required.
4. No repeat winners: Prior Landis Award recipients are not eligible.
5. Federal constraints: Mentors who are federal employees in certain capacities may be excluded, and mentors listed as PI need to ensure they can meet eligibility requirements in the current notice.
6. Conflict controls: Judges/review staff and immediate relations of key competition participants are excluded from eligibility to avoid conflicts.

The rule set is narrow and specific. If one element fails, nominations and invitations are not useful.

Institutional eligibility checkpoints

1. The institution must currently employ the nominated mentor.
2. The mentor must be approved internally by the institution.
3. The institution must be incorporated and have a primary U.S. place of business.
4. The institution cannot be a federal entity.
5. The institution must agree to accept and administer the cash award on behalf of the winner.

Because prizes flow to institutions, this can create administrative friction for institutions with strict compliance requirements or unusual legal processes. Engage your grants office and admin support early.

Application and submission process (what to prepare)

The process is staged and often misunderstood. Use this as a planning sequence.

Stage 1: Trainee nomination (Feb 27 to Apr 24, 2026)

• Gather a clear nomination narrative from one or more trainees.
• Ensure nominations are direct trainee statements.
• Use the official form link on the NIH page.
• No mentoring application template is required at this point; quality and credibility of the mentoring story matter more.

The key risk in Stage 1 is a weak narrative with generic language. If you mention “great mentor” but do not provide concrete outputs (publication, training, trainee placements, rigor culture), reviewers have little evidence.

Stage 2: Mentor invitation and full submission (deadline May 29, 2026)

Only mentors with at least two nominations and eligible standing are invited to submit. At this stage, the required package becomes much more detailed:

• Signed participation and consent form with institutional approval,
• Institution letter on official letterhead approving participation and accepting funds,
• Mentoring philosophy statement (1–3 pages),
• Updated CV (NIH explicitly says CV, not NIH biosketch),
• Two representative papers from the past 5 years with different trainees as primary authors,
• Active NINDS grant number with mentor as PI/mPI,
• Current and former trainee list with outcomes,
• 8 to 10 recommendation letters from trainees (first-hand mentoring evidence).

All recommendation letters should come from individuals with direct mentoring evidence; the competition explicitly expects directness and discourages pooled or harmonized endorsements.

Submission timing is strict: required material must be complete and uploaded by the stated deadline. The page indicates NIH Box and an email backup path, but even when email is offered, timing and completeness still matter.

Contact and support workflow

The official contact listed is [email protected]. If a question is ambiguous (especially around PI status, grant activity interpretation, or institution eligibility), use this contact and document your correspondence trail. The page also highlights that competition rules and requirements can be modified or canceled by NIH in their discretion, so candidates should read the latest language before finalizing late-stage documents.

Timeline: a planning model for lab teams

The page gives the following key milestones:

• Eligibility nomination period: Feb 27 – Apr 24, 2026
• Invitations to eligible nominees: anticipated May 1, 2026
• Prize competition full submission deadline: May 29, 2026
• Pre-screening and initial review: Jun 1 – Jun 26, 2026
• Judging and final selections: Jun 29 – Jul 24, 2026
• Anticipated winner announcement: Aug 21, 2026

A robust lab strategy can use this sequence to build a realistic workback:

1. Mid-February to early March: coordinate internal eligibility check and identify at least 3 potential nominators among trainees.
2. Early March to late March: collect specific mentoring evidence and finalize who can provide independent testimony.
3. Late March to early April: prep nominee summaries and submission drafts.
4. By Apr 24: complete nominations in the system.
5. Early May: set up submission foldering and institutional approvals.
6. By May 29: package and submit full docs in first complete pass.

This reduces stress and avoids the common “last-minute letter chase” failure.

How submissions are judged

The evaluation criteria are published and explicitly weighted equally (25% each) across four buckets:

1. Scientific excellence and rigor in mentoring,
2. Facilitation of trainee career progression,
3. Facilitating trainee contributions to science,
4. Contribution to excellence in research training.

Each submission is reviewed in two stages: first compliance-based pre-screening, then merit evaluation by federal staff for top submissions. High-quality evidence is cumulative, not single-point. A mentor can present an excellent philosophy but weak outcomes; without measurable results in at least some of the criteria, review scores drop.

Common mistakes and practical fixes

Mistake: treating it like a normal research grant

Grant-writing logic emphasizes novelty and feasibility; this opportunity requires mentorship outcomes and evidence of mentoring pathways. A “science proposal” with little trainee-specific output will underperform.

Mistake: underestimating institutional paperwork

Because the cash award goes to the institution, missing institutional approvals disqualifies strong candidates. Include that letter, legal title block, and explicit acceptance statement from the start.

Mistake: asking trainees to over-edit each other’s letters

Submission guidance says recommendations should be individually composed and first-hand. The review team expects independent witness-like quality, not coordinated consensus text.

Mistake: submitting incomplete package

Eligibility compliance is strict in stage transitions. If any required file is missing at submission stage, the package may not be considered, even if the mentoring quality is compelling.

Mistake: not aligning submission with NIH criteria examples

The judging examples provide useful language for evidence: specific mentoring practices, training outcomes, publication quality, and inclusion-oriented mentoring behavior. Include examples tied directly to those categories rather than generic claims.

Mistake: ignoring conflict-of-interest controls

Mentors cannot be participants in conflict roles (reviewers, judges, or associated team members in competition execution). Mentors and institutions should complete a full rule check for all involved personnel.

Preparation checklist (to stay compliant)

Use this checklist as a working script:

• Confirm mentor active grant status and tenure timeline.
• Confirm institution type (non-federal, U.S. place of business) and approval pathway.
• Confirm two independent trainee nominators are available.
• Confirm whether each trainee recommender can submit independently.
• Confirm mentor CV includes mentorship evidence and relevant outcomes.
• Compile 8–10 trainee recommendation letters (from trainees with direct mentoring history only).
• Compile 2 papers with different trainee primary authors from last 5 years.
• Validate all eligibility assumptions in writing before final submission.
• Confirm submission method and deadline at least 72 hours before cutoff.

FAQ grounded in the official guidance

Are mentors required to solicit their own nominations?

No. Nominations must be submitted by trainees and should not be solicited by mentors or institutions.

Where does the money go?

The award is paid directly to the institution for mentoring-related trainee development support. It is not paid directly to the mentor.

Can an institution win multiple prizes?

Yes, if both mentors and institutions meet rules and are found eligible.

Can a prior Landis winner reapply?

No. Prior recipients are not eligible again.

Can mentors be foreign visitors at US institutions?

The page requires institution and rule compatibility and emphasizes legal/institutional compliance. The primary explicit filter is listed as US-based institution and active NINDS-supported framework; if this does not match your status, confirm with NIH contact before planning a full package.

Are letters from current and former trainees enough?

Yes, but they should be direct and independent. The page explicitly expects one set of materials from nominators/trainees, with emphasis on direct evidence, not solicited general praise.

Risks to track before submission

• Discretionary program changes: NIH reserves rights to modify or cancel all or part of the competition.
• Eligibility drift: the rules are dated and could be updated after your early planning.
• Submission completeness: an incomplete submission in invited stage can fail regardless of prior nomination strength.
• Institutional delays: internal legal, grants, or HR review can become the pacing item.

Set a final internal compliance checkpoint at least four business days before the NIH deadline for any potential signatures.

Why this matters for 2026–2027 applicants

Even if you are not directly preparing an immediate submission, the structure of this opportunity is useful for planning mentorship systems over the next cycle. It rewards institutional mentorship culture, trackable trainee impact, and written evidence practices that also improve broader grant applications and internal reviews.

For principal investigators and mentors with deep NIH engagement, the award can also act as a demonstration signal in recruiting, retention, and training quality narratives. For trainees, nomination participation builds professional visibility into mentorship ecosystems and may strengthen networking with mentors committed to structured training.

If your cycle is not fully mature yet, consider this as a mid-cycle readiness exercise: collect the required outputs now, then decide whether to apply when the process opens.

Official links

• Official competition page: https://www.nih.gov/challenges/ninds-landis-award-outstanding-mentorship
• Submission contact: [email protected]
• Nominated form / direct resources: https://forms.cloud.microsoft

The official page and linked resources are the source of record and should be checked for any post-31 May updates before you build final materials.